HHS/FDA open Indian offices
This article was originally published in The Tan Sheet
Health and Human Services Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach announce Jan. 15 the agencies have offices established in New Delhi, and Mumbai, India. Ten HHS/FDA officials will be assigned in India "to work closely with industries that ship food and medical products to the United States, to improve safety and quality, which will facilitate the smooth flow of trade," HHS says. FDA also has a presence in China, Central America and Europe. As part of its Beyond Our Borders Initiative, the agency says it will expand in 2009 to Mexico, the Middle East and South America and open additional European sites (1"The Tan Sheet" Jan. 28, 2008, p. 3)
You may also be interested in...
FDA is in the early stages of developing "boots on the ground" programs in five regions overseas in an effort to improve the quality of imported products at their source, Commissioner Andrew von Eschenbach said Jan. 24 at a media briefing on food safety issues
Sandoz has closed its deal to acquire the Cimerli US ranibizumab biosimilar business from Coherus “ahead of anticipated timelines.”
Lilly’s CEO indicates that the long-standing IPR debate that has generally divided the developed and developing world is largely a “false narrative.” The executive also called for lowering regulatory barriers in India amid expectations of the potential debut of Zepbound/Mounjaro in the country next year.